CD19, Inhibitors

CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

Veröffentlicht: 17.03.2026 um 21:17 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | boerse | 68741760 |